Introduction

Percutaneous pain intervention has produced, over the past several decades, a steady stream of specialized needle-based instruments, each carrying its own trademarked name. In South Korea, two independent lineages illustrate this pattern: one in which the cutting edge of the acupotomy (a needle-knife descended from traditional Korean medicine) has been removed and patented, and another in which a dissection needle purpose-built for adhesiolysis was developed within anesthesiology and pain medicine and formally published in international journals. The two lineages emerged from different clinical traditions, yet they converge on the same intermediate form: an instrument that is inserted like a needle but, lacking a cutting edge, does not transect tissue.

This article traces the design logic of both domestic lineages, establishes that the same underlying principle has long been formalized in the Western pain-medicine literature on nerve-block needles, and then compares the three lineages on engineering and evidentiary grounds. Rather than naming specific products or practitioners, the aim is to map the genealogy and evidentiary standing of "blunt-tip needle" as a design category in its own right.

Classifying minimally invasive percutaneous instruments by transection mechanism is not a novel move original to this piece. A recent international review classified the several minimally invasive instruments used in carpal tunnel release by cutting direction (retrograde, antegrade, or bidirectional) and by the presence or absence of a safety mechanism (Korenblit M, et al. 2026); that review concerns carpal tunnel release and is not evidence for the efficacy of adhesiolysis instruments; this article draws on it only as a methodological precedent for classifying instruments by mechanism rather than by name. This article applies the same line of inquiry to percutaneous adhesiolysis and pain procedures.

Discussion

1. Classifying invasive instruments along a cutting-power spectrum

Percutaneous invasive instruments can be sorted, roughly, into three categories by tip geometry.

  • Filiform needle (毫鍼): thin and sharp. It has no cutting function; its purpose is acupoint stimulation.
  • Blunt-tip needle: as thick-bodied as an acupotomy or as slender as a nerve-block needle, but with a rounded, non-cutting tip. It penetrates the skin but does not transect tissue.
  • Acupotomy / needle-knife (針刀): a needle-gauge shaft terminating in a wedge-shaped flat blade (刀刃, roughly 0.8 mm). It both penetrates and transects.

Both domestic patented lineages examined here fall into the second category. This is frequently misunderstood, because a rounded tip is often mistaken for an instrument incapable of skin penetration. The same logic that surgeons invoke in distinguishing blunt from sharp dissection applies here: a blunt-tip needle pushes through weakly bonded planes — adhesions, fascial interfaces — while displacing, rather than transecting, resilient structures such as nerves and vessels.

2. Domestic patented blunt-tip needles derived from acupotomy

A category of domestically patented percutaneous needles exists in which the wedge-shaped cutting edge of an acupotomy has been removed and the tip machined into a rounded form. Whether an individual instrument is registered as a design patent or a utility patent, and under which claims, must be confirmed from the patent gazette itself; this inquiry did not do so. In any case, patent registration is a judgment of novelty and inventive step under patent law, not evidence that therapeutic efficacy or clinical safety for a given condition has been established.

According to the literature on domestic acupuncture-related patent trends, invasive acupuncture-related instruments, including the acupotomy lineage, constitute an area in which a substantial number of patents have been filed domestically, with numerous derivative forms registered primarily as shape variations. Within the scope of this inquiry, however, the precise dimensions (diameter, length) of individual patented instruments could not be confirmed through the academic literature; cross-checking the original patent specifications remains a task for follow-up work.

This opacity around specification is not unique to the domestic context. Recent literature on the specification and standardization of acupotomy-type instruments notes that tip geometry, length, material, and multifunctional structural design vary considerably across practitioners and manufacturers in clinical practice, and that appropriate instrument-specification selection is essential both to enhance therapeutic efficacy and to reduce procedural risk (Jing Y, et al. 2026). In other words, morphological modification — including the presence or absence of a cutting edge — is common across the broader acupotomy family, but independent validation of the safety and efficacy of each individual variant remains uncommon.

3. A domestically developed instrument published in international journals: fluoroscopy-guided interventional microadhesiolysis

A separate domestic lineage was developed and formally published in international journals. A paper reporting a nonsurgical adhesiolysis technique for adhesive capsulitis of the shoulder specified the exact dimensions of three purpose-built needles as follows.

"The Round and Flexed Round needles are 1.2 mm in diameter and 80 mm long. Ahn's Needle is 0.7 mm in diameter and 65 mm long." (Ahn K, Lee YJ, Kim EH, Yang SM, Lim TK, Kim YS, Jhun HJ. Interventional microadhesiolysis: A new nonsurgical release technique for adhesive capsulitis of the shoulder. BMC Musculoskeletal Disorders. 2008;9:12.)

During the procedure, the thickest needle is inserted through skin over the middle of the supraspinatus and advanced beneath the acromion and acromioclavicular joint, sliding along the fascial plane under real-time fluoroscopic guidance to release subacromial adhesions. Although mechanical release by the moving needle is the core of the procedure, the paper states that after each release phase about 5 ml of diluted triamcinolone acetonide (0.4 mg/ml) was introduced along the adhesiolysis route to prevent re-adhesion, and that the procedure was performed under intravenous propofol sedation. The needles are described as derived from Gunn's intramuscular stimulation (IMS) needle and made thicker; the design was a case series of ten patients without a control group. The case should therefore be read not as "treatment by the needle alone" but as an early clinical report that disclosed the specifications and technique of a dedicated blunt-tip instrument. (Corrected 22 September 2026 — the first version wrongly stated that no medication was injected.)

This technique was also applied to the spine, and a clinical report applying it to lumbar spinal stenosis was published in a domestic anesthesiology journal (Han SS, Lee SJ, Lee CJ, Lee SC. The Effects of Fluoroscopy Guided Interventional Microadhesiolysis and Nerve Stimulation (FIMS) in Lumbar Spinal Stenosis. Korean Journal of Anesthesiology. 2006;51(1):82-88).

4. The Western pain-medicine literature on blunt-tip nerve-block needles

The safety rationale for blunt-tip design had already accumulated within anesthesiology and pain medicine well before the domestic cases above were published. The core literature is as follows.

Selander D, Dhunér KG, Lundborg G. Peripheral nerve injury due to injection needles used for regional anesthesia. An experimental study of the acute effects of needle point trauma. Acta Anaesthesiologica Scandinavica. 1977;21:182-188.

What this rabbit sciatic-nerve study compared was not a blunt-tip needle in the modern sense but two injection needles with bevel angles of 14° and 45°. The 45° (short-bevel) needle produced fascicular damage less frequently and was therefore recommended for clinical anesthesia. The study is thus evidence that the relationship between needle-tip geometry and peripheral nerve injury has been examined experimentally since the 1970s, not evidence that the safety of blunt-tip needles was established at that time. For blunt tips in general, the proposition to be drawn is "may reduce the probability of injury," not "eliminates injury."

Sala-Blanch X, Ribalta T, Rivas E, Carrera A, Gaspa A, Reina MA, Hadzic A. Structural injury to the human sciatic nerve after intraneural needle insertion. Regional Anesthesia and Pain Medicine. 2009;34:201-205.

This study inserted a blunt needle (30° bevel) and a sharp needle (15° bevel) five times each into cryopreserved human sciatic nerve specimens and examined 520 fascicles microscopically; it reported that, among the fascicles in contact with the needle path, four (3.2%) and one intraneural blood vessel were damaged in the sharp-needle group, whereas no fascicular or vascular damage was observed in the blunt-needle group. Because this was a cadaveric experiment, the findings cannot be translated directly into a clinical injury rate for actual procedures. This is experimental evidence for the same design goal — "the nerve is not cut" — that the domestic instruments above claim to embody.

Heavner JE, Racz GB, Jenigiri B, Lehman T, Day MR. Sharp versus blunt needle: A comparative study of penetration of internal structures and bleeding in dogs. Pain Practice. 2003;3:226-231.

In anesthetized dogs, 18- to 25-gauge blunt and sharp needles were driven at the kidney, liver, renal artery, intestine, and spinal nerve roots. Blunt needles never punctured the renal artery, spinal nerve roots, or intestine and rarely penetrated the kidney, but every attempt on the liver with blunt needles succeeded. The accurate proposition is therefore not "blunt needles do not penetrate vital structures" but "under experimental conditions, blunt needles were less likely than sharp ones to penetrate some vital structures or cause bleeding." One co-author of this paper is the inventor credited for a separate epidural adhesiolysis catheter technique, illustrating that, within Western pain medicine itself, the concepts of "blunt-tip design" and "percutaneous adhesiolysis" have long belonged to a single line of inquiry.

Prakash S, Kumar A. Needle tip and peripheral nerve blocks. Journal of Anaesthesiology Clinical Pharmacology. 2018;34(1):129-130.

This letter cites the studies above, discusses the increased resistance and tactile feedback of short-bevel, non-cutting needles as they pass through tissue, and supports their use. One may say that discussion of the tissue interaction and nerve-injury risk of short-bevel needles has accumulated in the anesthesiology literature; this inquiry found no basis for asserting that it has become an established standard of formal training.

5. The evidentiary standing of acupotomy

A substantial number of systematic reviews on acupotomy have been published in international journals. Kwon et al. (2019) synthesized eleven systematic reviews (including sixty-nine randomized controlled trials) on the clinical effectiveness and safety of acupotomy, reporting significant effects for frozen shoulder, cervical spondylosis, third lumbar transverse process syndrome, trigger finger, knee osteoarthritis, and lumbar spinal stenosis (Kwon CY, Yoon SH, Lee B. Clinical effectiveness and safety of acupotomy: An overview of systematic reviews. Complementary Therapies in Clinical Practice. 2019;36:142-152). The same paper notes, however, that because acupotomy is more invasive than acupuncture, more systematic safety surveillance is warranted.

This suggests that the acupotomy lineage — including blunt-tip patented derivatives with the cutting edge removed — is not evidence-free; rather, it occupies a stage in which "evidence for the parent technique continues to accumulate, while independent clinical research on individual derivative patented instruments remains comparatively thin."

Comparison

ItemDomestic Patent A (acupotomy-derived blunt-tip needle)Domestic Development B (dedicated adhesiolysis needle, published internationally)Western nerve-block needle (short-bevel family)
Tip geometryBlunt (cutting edge removed from acupotomy)Blunt (dedicated design, e.g. 1.2 mm / 80 mm)Blunt (short bevel, roughly 45°)
Skin penetrationYesYesYes
Cutting functionNoneNoneNone
Mechanism of actionPhysical insertion and mechanical stimulationFascial-plane release under fluoroscopic and ultrasound guidance (with diluted steroid injected after release)Primarily drug delivery and nerve blockade
Imaging guidanceNo explicit mention found in public materialsFluoroscopy combined with ultrasoundVaries by procedure (ultrasound among others)
Instrument-level academic evidenceNot identified (no independent academic paper found; patent filings predominate)Published in international journals (methodology and specifications disclosed; case series of ten, no control group; drug co-administered, effect not attributable)Experimental studies of nerve injury and tissue penetration, plus reviews
Systematic review of the parent techniqueExists (acupotomy; Kwon 2019)Not identified for this specific technique (the parent concept of epidural adhesiolysis has a separate literature)Extensive (numerous standard reviews)
Regulatory / disclosure characterPatent (type and claims to be confirmed from the gazette)Journal publication (methodology disclosed) plus domestic patentCommercial medical device (multiple manufacturers)

Conclusion

The two domestic lineages of patented blunt-tip percutaneous needles arose independently from different clinical traditions — the acupotomy lineage within Korean medicine, and the adhesiolysis lineage within anesthesiology and pain medicine — yet they converge, at the engineering level, on the same design principle: a rounded tip that penetrates without transecting. Western anesthesiology and pain medicine has examined the relationship between needle-tip geometry and peripheral nerve injury experimentally since at least the 1970s, and the direct blunt-versus-sharp comparisons of the 2000s (Heavner 2003, Sala-Blanch 2009) were built on that foundation.

The substantive difference between the two domestic lineages lies not in tip geometry but in procedural protocol and the level of publicly disclosed evidence. Western nerve-block needles function primarily as conduits for drug delivery and nerve blockade, whereas the domestic lineages take mechanical release of tissue planes by the moving needle as their core process (although the Ahn lineage injects diluted steroid after release, so it cannot be described as treatment by the needle alone). The two also differ in evidentiary standing. The internationally published lineage (B) disclosed its methodology and needle specifications in a peer-reviewed paper, and its parent concept — adhesiolysis via a blunt-tip instrument — is broadly supported in the Western pain-medicine literature. The acupotomy-derived lineage (A) is backed, at the level of its parent technique, by numerous systematic reviews, but no independent clinical research on the individual patented instrument itself was identified in this inquiry.

One further distinction is needed when reading the evidence for lineage B. Adhesions fall into two classes according to their cause. Cicatricial adhesions left after trauma, surgery, or prolonged immobilization are scars that remain once inflammation has ended; for these, mechanical release is itself the treatment. Adhesions that accompany chronic inflammation, by contrast, re-form for as long as the inflammation persists; here release is an adjunct, and the centre of treatment lies in extinguishing the inflammation. The adhesive capsulitis treated in Ahn 2008 is the paradigm of the latter — synovitis progressing to capsular fibrosis — and the paper states that the roughly 5 ml of diluted triamcinolone introduced along the same route immediately after release was given "to prevent re-adhesion." Because the efficacy of corticosteroid injection alone in this condition is established by numerous meta-analyses, the drug's share in the improvement observed in the case series cannot be ruled out even at a low concentration, and what mechanical release added cannot be judged from a design without a needle-only or drug-only arm. The literature on this technique identifiable in PubMed consists of the 2008 case series and a 2009 case report; no subsequent study has separated the two effects. The "international publication" of lineage B therefore means that instrument specifications and technique were disclosed, not that the release effect of the blunt-tip needle was demonstrated; and if the proper indication of the blunt-tip needle is to be sought, the question should be put first to cicatricial rather than chronic inflammatory adhesions.

Translated into the framework of Korean medicine, this distinction becomes one of external treatment (外治, oechi) and internal treatment (內治, naechi). The needle lineages, blunt-tip and acupotomy alike, are all external treatment. The role that the corticosteroid plays in the Western adhesiolysis protocol — calming inflammation at the released site to prevent re-adhesion — is taken in Korean medicine jointly by pharmacopuncture applied directly to the released site and by internal treatment with herbal medicine that addresses the systemic ground. Cicatricial adhesions may be resolved by external treatment alone; adhesions accompanying chronic inflammation cannot be resolved by release alone, and treatment is constituted only when external treatment — release with pharmacopuncture added at the released site — is combined with internal treatment that addresses the inflammatory ground with herbal medicine. This follows logically from the classification of adhesions by cause. The question to ask of the blunt-tip needle is therefore not "is the needle effective on its own" but "for which type of adhesion, and combined with what"; this article leaves that question as its successor task.

In sum, each lineage has a history approaching two decades. Lineage B is documented by a Korean patent application filed in 2004 (cited in Ahn 2008) and by papers published in 2006 and 2008; lineage A is documented in the domestic acupuncture-patent literature. Both implemented the shared blunt-tip principle within their own clinical traditions, adapted to their own indications and protocols. This article has set out the differences in implementation and in publicly available evidence; it neither negates nor endorses the clinical value of either procedure. Its conclusion is limited to a methodological proposal: only when instruments are classified by mechanism, protocol, and level of evidence rather than by name does comparison across lineages become possible.

References

  1. Ahn K, Lee YJ, Kim EH, Yang SM, Lim TK, Kim YS, Jhun HJ. Interventional microadhesiolysis: A new nonsurgical release technique for adhesive capsulitis of the shoulder. BMC Musculoskeletal Disorders. 2008;9:12. DOI: 10.1186/1471-2474-9-12.
  2. Han SS, Lee SJ, Lee CJ, Lee SC. The Effects of Fluoroscopy Guided Interventional Microadhesiolysis and Nerve Stimulation (FIMS) in Lumbar Spinal Stenosis. Korean Journal of Anesthesiology. 2006;51(1):82-88.
  3. Selander D, Dhunér KG, Lundborg G. Peripheral nerve injury due to injection needles used for regional anesthesia. Acta Anaesthesiologica Scandinavica. 1977;21:182-188.
  4. Sala-Blanch X, Ribalta T, Rivas E, Carrera A, Gaspa A, Reina MA, Hadzic A. Structural injury to the human sciatic nerve after intraneural needle insertion. Regional Anesthesia and Pain Medicine. 2009;34:201-205.
  5. Heavner JE, Racz GB, Jenigiri B, Lehman T, Day MR. Sharp versus blunt needle: A comparative study of penetration of internal structures and bleeding in dogs. Pain Practice. 2003;3:226-231.
  6. Prakash S, Kumar A. Needle tip and peripheral nerve blocks. Journal of Anaesthesiology Clinical Pharmacology. 2018;34(1):129-130. PMCID: PMC5885433.
  7. Kwon CY, Yoon SH, Lee B. Clinical effectiveness and safety of acupotomy: An overview of systematic reviews. Complementary Therapies in Clinical Practice. 2019;36:142-152. DOI: 10.1016/j.ctcp.2019.07.002.
  8. Jing Y, Qin Y, Tong Y, Qiao H, Yu H, Zhang Y, Liu F, Guo C, Yang J, Liu Q, Yang X. Status and prospects of acupotomy tool specifications and standardization. Guidelines and Standards of Chinese Medicine. 2026;4(1):1-6. DOI: 10.1097/gscm.0000000000000094.
  9. Korenblit M, Haas EJ, Esch EM, Orfahli L, Mares O, Greyson M. A Mechanism-Based Classification and Review of Endoscopic and Ultrasound-Guided Carpal Tunnel Release. Journal of Clinical Medicine. 2026;15(16):6130. DOI: 10.3390/jcm15166130.
연구 목록으로